Skip to main content

Table 3 The patient characteristics

From: Concurrent hyperfractionated chemoradiotherapy for head and neck squamous cell carcinoma: the prognostic impact of the overall treatment time and completion rates of chemotherapy

Variable n = 69 (%)
Age (years)
 Median (range) 69 (40–85)
Gender
 Male 60 (87)
 Female 9 (13)
Performance status
 0 12 (17)
 1 46 (67)
 2 10 (15)
 3 1 (1)
Tumor type, TNMa
 Nasopharyngeal ca. 5 (7)
  T1N2M0 1
  T1N3M0 1
  T2N1M0 3
 Oropharyngeal ca. 15 (22)
  T1N0M0 1
  T1N2M0 4
  T2N0M0 1
  T2N1M0 2
  T2N2M0 1
  T3N1M0 1
  T4N1M0 1
  T4N2M0 1
  T4N3M0 3
 Hypopharyngeal ca. 22 (32)
  T1N0M0 2
  T1N2M0 1
  T2N0M0 8
  T2N1M0 1
  T2N2M0 4
  T3N2M0 2
  T4N0M0 2
  T4N2M0 2
 Laryngeal ca. 27 (39)
  T2N0M0 22
  T2N1M0 1
  T2N2M0 2
  T3N0M0 1
  T3N2M0 1
  1. aInternational Union Against Cancer tumor, node, metastasis classification, 6th edition